Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CancerCenter.AI is a private Polish healthtech company focused on AI-enabled cancer diagnostics rather than drug development. The company offers a web-based digital pathology and radiology platform, including pathology image viewing and annotation, teleradiology, laboratory information system functionality, and AI-assisted analysis tools for oncology workflows. Its products include PathoPlatform, Radiology Platform, LIS functionality, and PathoCam, which converts a conventional microscope and camera setup into a lower-cost digitization workflow for pathology slides. The company appears to serve hospitals, laboratories, pathologists, and radiologists seeking faster, more standardized, and more collaborative cancer diagnosis. Available materials indicate a commercial software and diagnostics-support business model rather than a therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CancerCenter.AI.